Phoenix Biotech Acquisition Corp. (PBAX)


+0.05 (+0.00%)
Symbol PBAX
Price $10.9
Beta 0.041
Volume Avg. 0.00M
Market Cap 68.084M
Shares () -
52 Week Range 10.22-11.83
1y Target Est -
DCF Unlevered PBAX DCF ->
DCF Levered PBAX LDCF ->
ROE 2026.88% Strong Buy
ROA -28.42% Sell
Operating Margin -
Debt / Equity -25.46% Neutral
P/E -31.14 Strong Sell
P/B -12.60 Strong Sell


Consensus EPS

Upgrades & Downgrades

Mr. Christopher B. Ehrlich M.B.A.
Financial Services
Shell Companies
NASDAQ Global Market

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.